Filing Flows

Filing Flows › Progyny (PGNY) › Next earnings date

Progyny (PGNY) earnings: beat the estimate

Progyny (PGNY) reported on Nov 4, 2026 and beat the EPS estimate: $0.52 against $0.51 (+2.2%). Revenue was $341M for Q3 2026, +9% year over year. It beat the EPS estimate in 100% of the quarters on record.

Last result+2.2% vs estimate
Beat rate100%

The last report

Progyny reported revenue of $341M for the third quarter 2026 (+9% Y/Y), net earnings $26.3M: Fertility benefits services revenue $223M, Pharmacy benefits services revenue $118M. How it makes money → · Every quarter →

Progyny: EPS against the estimate, last 5 reportsProgyny: EPS against the estimate, last 5 reportsEstimateReported$0.39$0.45Nov 25$0.40$0.48Feb 26$0.44$0.50May 26$0.52$0.55Aug 26$0.51$0.52Nov 26
Latest (Nov 26): Estimate $0.51, Reported $0.52.

Progyny's latest quarter

Progyny, Q3 2026: revenue $341M (+9% year over year), operating margin 10.3%, net earnings $26.3M, operating cash flow $56.6M. The chart follows the revenue to costs, profit and cash.

Questions

Did Progyny beat earnings?

Progyny (PGNY) reported on Nov 4, 2026 and beat the EPS estimate: $0.52 against $0.51 (+2.2%).

When does PGNY report earnings?

The next date is not set yet.

Does Progyny usually beat earnings?

It beat the consensus EPS estimate in 100% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.